Astra's Farxiga results may open up type 1 diabetes opportunity
FRANKFURT (Reuters) - AstraZeneca's Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up a additional market opportunity for the type-2 diabetes drug, the British drugmaker said in a statement on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: AstraZeneca | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Health | Insulin | UK Health